Form 4 for BCDA BioCardia, Inc.
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-10 · accession 0001437749-22-023876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-11 | 2022-10-10 | BCDA | McClung David | CFO | P - Purchase | $2.07 | +2,000 | 78.5K | +3% | +$4,140 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-10 | P | A | 2,000 | $2.07 | 78,518 | D | — | — | (F1) This transaction was executed in multiple trades ranging from $2.06 to $2.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. |